Vande Walle J - Search Results

1

Safety profile of desmopressin tablet for enuresis in a prospective study.

Van Herzeele C, De Bruyne P, Evans J, Eggert P, Lottmann H, Norgaard JP, Vande Walle J. Van Herzeele C, et al. Among authors: vande walle j. Adv Ther. 2014 Dec;31(12):1306-16. doi: 10.1007/s12325-014-0173-1. Epub 2014 Dec 12. Adv Ther. 2014. PMID: 25504157 Clinical Trial.

2

A new fast-melting oral formulation of desmopressin: a pharmacodynamic study in children with primary nocturnal enuresis.

Vande Walle JG, Bogaert GA, Mattsson S, Schurmans T, Hoebeke P, Deboe V, Norgaard JP; Desmopressin Oral Lyophilisate PD/PK Study Group. Vande Walle JG, et al. BJU Int. 2006 Mar;97(3):603-9. doi: 10.1111/j.1464-410X.2006.05999.x. BJU Int. 2006. PMID: 16469035 Clinical Trial.

3

Desmopressin resistant nocturnal polyuria secondary to increased nocturnal osmotic excretion.

Dehoorne JL, Raes AM, van Laecke E, Hoebeke P, Vande Walle JG. Dehoorne JL, et al. J Urol. 2006 Aug;176(2):749-53. doi: 10.1016/S0022-5347(06)00297-7. J Urol. 2006. PMID: 16813935

4

Desmopressin toxicity due to prolonged half-life in 18 patients with nocturnal enuresis.

Dehoorne JL, Raes AM, van Laecke E, Hoebeke P, Vande Walle JG. Dehoorne JL, et al. J Urol. 2006 Aug;176(2):754-7; discussion 757-8. doi: 10.1016/S0022-5347(06)00299-0. J Urol. 2006. PMID: 16813936

5

Characteristics of a tertiary center enuresis population, with special emphasis on the relation among nocturnal diuresis, functional bladder capacity and desmopressin response.

Dehoorne JL, Walle CV, Vansintjan P, Raes AM, De Guchtenaere AR, Van Laecke E, Hoebeke P, Vande Walle JG. Dehoorne JL, et al. Among authors: vande walle jg, walle cv. J Urol. 2007 Mar;177(3):1130-7. doi: 10.1016/j.juro.2006.10.093. J Urol. 2007. PMID: 17296432

6

Partial response to intranasal desmopressin in children with monosymptomatic nocturnal enuresis is related to persistent nocturnal polyuria on wet nights.

Raes A, Dehoorne J, Van Laecke E, Hoebeke P, Vande Walle C, Vansintjan P, Donckerwolcke R, Vande Walle J. Raes A, et al. Among authors: vande walle j, vande walle c. J Urol. 2007 Sep;178(3 Pt 1):1048-51; discussion 1051-2. doi: 10.1016/j.juro.2007.05.060. Epub 2007 Jul 16. J Urol. 2007. PMID: 17632162

7

Desmopressin resistant nocturnal polyuria may benefit from furosemide therapy administered in the morning.

De Guchtenaere A, Vande Walle C, Van Sintjan P, Donckerwolcke R, Raes A, Dehoorne J, Van Laecke E, Hoebeke P, Vande Walle J. De Guchtenaere A, et al. Among authors: vande walle j, vande walle c. J Urol. 2007 Dec;178(6):2635-9; discussion 2639. doi: 10.1016/j.juro.2007.08.026. Epub 2007 Oct 22. J Urol. 2007. PMID: 17945291 Clinical Trial.

8

Pitfalls in studies of children with monosymptomatic nocturnal enuresis.

Vande Walle J, Van Laecke E. Vande Walle J, et al. Pediatr Nephrol. 2008 Feb;23(2):173-8. doi: 10.1007/s00467-007-0688-7. Epub 2007 Dec 4. Pediatr Nephrol. 2008. PMID: 18057964

9

Desmopressin 30 years in clinical use: a safety review.

Vande Walle J, Stockner M, Raes A, Nørgaard JP. Vande Walle J, et al. Curr Drug Saf. 2007 Sep;2(3):232-8. doi: 10.2174/157488607781668891. Curr Drug Saf. 2007. PMID: 18690973 Review.

10

Evidence of partial anti-enuretic response related to poor pharmacodynamic effects of desmopressin nasal spray.

De Guchtenaere A, Raes A, Vande Walle C, Hoebeke P, Van Laecke E, Donckerwolcke R, Vande Walle J. De Guchtenaere A, et al. Among authors: vande walle j, vande walle c. J Urol. 2009 Jan;181(1):302-9; discussion 309. doi: 10.1016/j.juro.2008.09.040. Epub 2008 Nov 14. J Urol. 2009. PMID: 19013601

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

237 results

Search Page